Expression pattern of the apoptosis-stimulating protein of p53 family in p53+ human breast cancer cell lines by Changsong Wang et al.
Wang et al. Cancer Cell International 2013, 13:116
http://www.cancerci.com/content/13/1/116PRIMARY RESEARCH Open AccessExpression pattern of the apoptosis-stimulating
protein of p53 family in p53+ human breast
cancer cell lines
Changsong Wang*, Chunfang Gao, Yanping Chen, Jian Yin, Ping Wang and Xuexia LvAbstract
Background: The apoptosis-stimulating protein of p53 (ASPP) family comprises three members, namely, ASPP1,
ASPP2, and iASPP. They regulate the promotive effect of p53 on apoptosis. Breast cancer (BC) remains as one of the
leading causes of cancer or cancer-related mortality among women. However, the relationship between the ASPP
family members and p53, as well as the dissemination and expression pattern of ASPP family members in p53+ BC,
has not been elucidated. Our objectives are to detect the expression of ASPP family members in p53+ BC cell lines
and determine its significance in tumor cell apoptosis.
Methods: The mRNA expression of ASPP family members in five p53+ BC cell lines was detected through RT-PCR
and assayed using Quality-one software. The p53 protein expression was detected by immunohistochemistry.
Afterward, the apoptosis indices of the five BC cell lines were detected by flow cytometry.
Results: The iASPP mRNA was expressed in Bcap-37, MCF-7, and HBL-100. Compared with the human peripheral blood
mononuclear cells, significant differences were found in the ASPP1 mRNA in Bcap-37, MDA-MB-231, MCF-7, and HBL-100
(p < 0.05), except that in ZR-75-30 (p > 0.05). The ASPP2 mRNA was expressed in MDA-MB-231, Bcap-37, and MCF-7, but
not in HBL-100 and ZR-75-30. The p53 protein was expressed in five breast cancer cell lines. ZR-75-30 and MDA-MB-231
apoptosis indices were higher than those of other breast cancer cell line and peripheral blood mononuclear cells
(p < 0.01).
Conclusions: The mRNA expression of ASPP family members varied in the five p53+ BC cell lines. The results also
verified that the family members have an important function in apoptosis, which was promoted by p53 protein.
ZR-75-30 BC showed high apoptosis index, without expression of any ASPP family members, indicating that the
pathway of apoptosis in this cell line may be related to other cell transduction pathway. MDA-MB-231, Bcap37,
and MCF-7 cell lines all expressed ASPP1/2. However, the apoptosis pathway in MDA-MB-231 is different from
those of the other two cell lines. The status of the different cell lines should also be considered when the functions
of the ASPP family members are examined.
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Breast cancer (BC) is the most common cancer among
women worldwide [1-4], with 692,200 and 691,300 pa-
tients in developed and developing countries, respect-
ively, in 2008 [5]. During BC development, genetic and
non-genetic factors have key functions such as in the
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reproduction in any medium, provided the ormutation and/or deletion of a few specific genes or
group of genes. More molecules have been found to
support the individual treatment and molecular clas-
sification of BC. The apoptosis-stimulating protein of
p53 (ASPP) family has recently been reported as an
apoptotic specific regulator of p53 [6-9]. ASPP family
members include three members: iASPP, which is an
inhibitory member that binds with p53 and interferes
with its apoptosis-induction ability [8]; and ASPP1 and
ASPP2 that bind with p53 protein to induce apoptosis oftd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Expression of ASPP family members mRNA in 5 BC
cell lines.
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ant factors in the apoptosis pathway, which is triggered
by p53 protein. A few published reports have shown
that the function of p53 protein is regulated by inhi-
biting iASPP over-expression in cancer cells to remove
its interference on p53 when iASPP cancer cells are
overex-pressed [10,11]. Elucidating the expression of
ASPP family members in BC cells, along with a better
understanding of the relationship between the expression
of individual ASPP family members and BC cell line
apoptosis, may facilitate the development of effective
strategies that provide effective therapy protocols to
BC patients. Investigating the functions of the ASPP
family members in in vitro expression in human BC cell
lines, such as in the ER-negative MDA-MB-231 (highly
invasive and metastatic cells) and ER-positive MCF-7
(weakly invasive and metastatic cells), offers an approach
to better understand the relation of the ASPP family in
BC evolution. Majority of the available data on the ex-
pression of the ASPP family members in BC cell lines are
somehow contradicting. Hence, examining the expres-
sion of these members in different human BC cell lines
is important.
Results
Evaluation of the mRNA expression of ASPP family members
by reverse transcription-polymerase chain reaction (RT-PCR)
ASPP1 mRNA expression was observed in four BC cell
lines (i.e., MDA-MB-231, Bcap-37, MCF-7, and HBL-100
cells). The expression levels were higher in MDA-MB-231,
Bcap-37, and MCF-7 than that in the mononuclear cells
(MNCs) and HBL-100. In addition, no expression was ob-
served in ZR-75-30. Higher ASPP2 mRNA expression was
observed in MNCs, MDA-MB-231, Bcap-37, and MCF-7,
but no ASSP2 expression was observed in HBL-100
and ZR-75-30. iASPP mRNA expression was observed in
MCF-7 and HBL-100, slight expression was observed in
Bcap-37, and no expression was found in MNCs, MDA-
MB-231, and ZR-75-30 (Figure 1).
Analysis of the expression of the ASPP family members
using Quality-one image scan
The optical density value of the ASPP family members
and β-actin were analyzed using Quality-one image
scan software, and the results showed the quantity of
the relative expression in the five BC cell lines. iASPP ex-
pression was observed only in Bcap-37, MCF-7, and
HBL-100. ASPP1 mRNA expression was significantly dif-
ferent among Bcap-37, MCF-7, HBL-100, MDA-MB-
231, and MNCs (p < 0.05), except in ZR-75-30. ASPP2
mRNA levels in MDA-MB-231, Bcap-37, and MCF-7
cell lines were higher than that in MNCs (p < 0.05). No
ASPP2 expression was detected in HBL-100 and ZR-75-30
(Table 1).P53 protein expression by immunochemistry and Western
blot analysis
The positive cells showed yellow nuclei. All five BC cell
lines reacted positively (Figure 2). Thus, p53 protein was
expressed in the five BC cell lines (Figure 3).
Apoptosis detection
To further explain the relationship between ASPP family
members and BC cells, the five BC cell lines were cul-
tured in vitro. Cell apoptosis was determined using flow
cytometry (FCM). The results are shown in Table 2. Apop-
tosis was found to be different among the cell lines with-
out any interference. The apoptosis indices of ZR-75-30
and MDA-MB-231 cell lines were higher than those of
Bcap-37, MCF-7, HBL-100, and MNCs (p < 0.01).
Apoptotic changes in ZR-75-30 and MDA-MB-231 through
transfection with pAd-p53-RNAi
To further demonstrate the relationship between p53
protein and the BC cell lines, we transfected the BC cell
lines ZR-75-30 and MDA-MB-231, with high apoptosis
indices, using pAd-p53-RNAi. Cell apoptosis was deter-
mined via FCM post-pAd-p53-RNAi transfection. The
results are shown in Table 3. The cell apoptosis index
decreased markedly after the interference plasmid was
transfected.
Discussion
The wild-type p53 is an important anti-oncogene and its
expression induces tumor cell apoptosis. P53 protein
binds with the DNA of damaged cells, which results
Table 1 The ratio of the integrated optical density (IOD) of ASPP family members and β-actin in BC cell lines
MNCs MDA-MB-231 Bcap-37 MCF-7 HBL-100 ZR-75-30
iASPP 0 0 0.3236 ± 0.0129 0.7052 ± 0.0229 0.7212 ± 0.0191 0
ASPP1 0.7612 ± 0.0143 1.0233 ± 0.0114* 1.0495 ± 0.0220* 1.0209 ± 0.0112* 0.9925 ± 0.0038* 0
ASPP2 0.6180 ± 0.0036 0.9981 ± 0.0457* 1.0576 ± 0.0194* 1.1667 ± 0.0119* 0 0
vs MNCs, *P < 0.05.
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repaired by the host or killed via apoptosis. Numerous
studies have shown that p53 protein increased mark-
edly in DNA-damaged cells. The process by which p53
protein induces cell apoptosis has not been elucidated.
The recent discovery of ASPP explained the p53-induced
cell apoptosis because this protein is a specific p53 regu-
lator [6-8]. The ASPP family is also the most effective
protein family that regulates p53 protein [6,12,13]. The
ASSP family comprises ASSP1, ASSP2, and iASPP, which
have diverse functions. ASSP1 and ASSP2 can activate
p53 to induce cell apoptosis, but iASPP inhibits p53 pro-
tein function. Therefore, p53-induced cell apoptosis canFigure 2 Expression of p53 in both BC cell lines. (A) MDA-MB-231. (B)be activated by ASSP1 and ASSP2 but can be inhibited
by iASPP.
To date, the status and expression pattern of the ASPP
family in BC cell lines have not been reported, and whether
the ASPP family could be a new therapy target in BC
patients remain unknown. In the current study, we ana-
lyzed the mRNA expression pattern of the ASPP family in
five p53+ BC cell lines using semi-quantitative RT-PCR
method. The results revealed that ASPP1 was expressed in
four BC cell lines. ASPP2 was expressed in MDA-MB-
231, Bcap-37, and MCF-7. iASPP was expressed only in
MCF-7, HBL-100, and Bcap-37. To further study the rela-
tionship between the ASPP family members and p53+ BCZR-75-30. (C) Bcap-37. (D) MCF-7. (E) HBL-100 (×200 magnification).
Figure 3 Western-blot result of p53 protein expression in 5 BC
cell lines.
Table 3 Apoptosis index of BC cell lines after transfected
p53 RNAi (%, x– ±s)
Cell lines Apoptosis index
MDA-MB-231 3.4 ± 0.11
ZR75-30 2.6 ± 0.37
MNCs 1.9 ± 0.44
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BC cell lines. Results showed that the apoptosis indices
of MDA-MB-231 and ZR-75-30 (non-expression iASPP)
were markedly higher than those of the other BC cell lines.
Our results further verified the relationship between the
ASPP family members and apoptosis in p53+ BC. Apop-
tosis induction in p53+ BC also involves other pathways
aside from the ASPP family transduction pathways.
According to a previous study, 4.1% and 1.5% of p53
binds with ASPP1 and ASSP2, respectively, in normal
cultural MCF-7 BC cell line, p53-ASPP2 complexes in-
crease to 3.4 times after the cells are UV-irradiated, and
p53-ASPP1 complexes remain unchanged [6]. These re-
sults revealed that protein binding of p53 with ASPP2 in-
creased markedly in DNA-damaged cells. Consequently,
inhibition of iASPP expression in MCF-7 cells by RNA
interference strategy increased apoptosis [14]. The binding
ability of ASPP1 with mutant-p53 was weaker than that
with wild-p53 protein. In addition, p53-DNA complexes
changed when ASPP1 and ASSP2 slightly changed, conse-
quently altering tumor cell apoptosis. In the present study,
the results revealed that the expression of the ASPP family
members vary among the different p53+ BC cell lines. P53
expression was also detected in the five BC cell lines, and
we infer that this difference was related to the status of the
p53 gene. P53 mutation was noted in approximately 30%
of patients with breast cancer. Thus, 70% of patients with
breast cancer exhibit wild-type p53. However, the progno-
sis and recurrence rate vary among patients, which may be
related to the status of p53 and the ASPP family members.
Therefore, we believe a new strategy must be used in treat-
ing different BC patients.Table 2 Apoptosis index of BC cell lines (%, x– ±s)
Cell lines Apoptosis index
MDA-MB-231 8.4 ± 0.18*
ZR75-30 8.9 ± 0.23*
Bcap-37 3.1 ± 0.73
MCF-7 2.1 ± 0.12
HBL-100 3.6 ± 1.04
MNCs 2.3 ± 0.13
*vs Bcap-37、MCF-7、 HBL-100 and MNCs, (P < 0.01).Finally, despite the increased awareness on the relation-
ship between the ASPP family and BC, many questions
remain unresolved, particularly regarding the functions
of the ASPP family members in p53+ BC cell lines. A few
reports have shown that ASPP1 and ASPP2 act as tumor
suppressors and iASPP as an oncogene [15,16]. iASPP
over-expression has been found in various tumor cells
[6,17]. Inhibition of iASPP over-expression may also be a
new strategy to continue the cancer-suppressing function
of p53 protein. ZR-75-30 BC, which did not express any
ASPP family member, exhibited a high apoptosis index.
This finding indicated that the apoptosis pathway in this
cell line may be related to other cell transduction pathway.
Simultaneously, different apoptosis indices were observed
in ASPP1 and ASPP2 expression BC cells (MDA-MB-231,
Bcap37, and MCF-7), indicating that apoptosis pathways
were diverse in these BC cell lines. These results predicted
that an intermediate link existed between the ASPP family
and p53. Two recent studies have reported that ASPP1
and ASPP2 bound with RAS to enhance p53 activity in
cancer cells [18]. ASPP1 inhibited apoptosis by controlling
YAP function [19], and the ASPP family members inter-
acted with other p53 family members (p63 and p73) to in-
fluence apoptosis effects [20]. These intermediate links
probably caused the difference in the apoptosis indices in
the p53+ BC cell lines. Our results also verified that the ex-
pression pattern of the ASPP family members was altered
in almost 80% of human BC cases, which was reported by
Bergamaschi et al. [13]. The ASPP family members may be
used as a new target for BC treatment [21,22], and the in-
vestigation of the function of the ASPP family should con-
sider the status and characteristics of the ASPP family
members in p53+ BC cell lines.
Materials and methods
BC cell lines
MDA-MB-231, Bcap-37, MCF-7, HBL-100, ZR-75-30,
and MNCs were maintained in Dulbecco modified
Eagle medium supplement with 100 IU/mL penicillin-G,
100 μg/mL streptomycin sulfate, (Gibco/Life Technologies,
Grand Island, NY, USA), and 10% fetal bovine serum (FBS,
Natocor, Argentina) at 37°C under 5% CO2 in a humidified
atmosphere. The medium was changed every 3 d to 4 d.
The cells were used up to passage 4. The experimental pro-
tocols were approved by the ethics committee of the 150th
Hospital, PLA (20121008023).
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Total RNAs were extracted from the five BC cell lines
using Tripure isolation reagent (Roche, USA).
RNA expression determination by RT-PCR
RT-PCR kits (TaKaRa, Japan) were used to synthesize
cDNA from 5 μL of total RNA. cDNA synthesis was per-
formed, as suggested by the kit protocol, using AMV re-
verse transcriptase. Reverse transcription was performed
for 2 min at 94°C for one cycle, and then at 94°C for
40 s, at 72°C for 40 s for 30 cycles, and finally at 72°C
for 10 min for one cycle extension. Appropriate temper-
atures for ASPP1, ASPP2, and iASPP were 62, 59, and
60°C, respectively. cDNA (5 μL) was used in amplifying
the target regions of ASPP1, ASPP2, or iASPP. β-Actin
cDNA fragments were also amplified as positive control.
The RT-PCR primers of ASPP1, ASPP2, and iASPP were
designed using Primer Premier 5.0 software (Table 4).
The nucleotide sequences of these primers and their
PCR conditions are summarized in Table 1. After PCR,
10 μL of product was mixed with 1 μL of 10× loading
dye, and was subsequently placed on 1.4% agarose gel.
Electrophoresis was performed at 70 V under ambient
temperature. The bands on the gels were visualized using
ethidium bromide staining.
RT-PCR production analysis
The lengths of the PCR products of ASPP1, ASPP2, and
iASPP were 300, 180, and 753 bp, respectively. Electro-
phoresis profiles were analyzed using Quality-one image
scan software (Bio-Rad Inc., USA). The ratio of the inte-
grated optical density of ASPP and β-actin represented
the mRNA level.
Immunocytochemistry
The BC cell lines were used to evaluate the p53 protein
expression thrice via immunocytochemistry assays. BC
cells (6 × 105 cells/well) were fixed using acetone solu-
tion. Endogenous peroxidase activity was then blocked,
and the BC cells were incubated with primary human
Abs, 10 μL anti-p53 (AB1862, Chemicon, 1:20), and anti-
AE1AE3 as a positive control (IR053, Dako). According to
the manufacturer’s recommendations, a peroxidase-based
immunocytochemistry staining method (K0690, Dako) was
used for primary Ab detection, and a 3,3′-diaminobenzi-




iASPP 5′-GATGAACTGACCAAGCA-3′was used as chromogen. Negative controls without primary
Abs were also prepared at the same time. Each sample was
assayed in quadruplicate.
Detection of p53 protein expression using Western
blot analysis
Cells were collected and lysed in RIPA lysis buffer
(50 mM Tris–HCl, 150 mM NaCl, 1% NP-40, 0.1% SDS,
5 mM benzamidine, 1 μM aprotinin A, 1 μM pepstatin,
1 μM leupeptin, 1 mM PMSF, pH 7.4). Supernatants were
loaded on a SDS-PAGE gel and transferred to PVDF mem-
branes. After blocking for 1 h at room temperature with
PBS buffer containing 6% non-fat milk powder, membranes
were incubated with mouse anti-p53 primary antibody
(2 μg/mL, DO-7, DAKO) at 4°C overnight and were subse-
quently incubated with the secondary HRP-IgG antibody
at room temperature for 1 h.
Detection of apoptosis through FCM
After collection, the cells were washed with ice-cold PBS
buffer twice. Cell concentration was adjusted to 2 × 106
cells/mL. Subsequently, Annexin-V/FITC solution, PI solu-
tion, and HEPES buffer were mixed together (1:50). More-
over, 100 μL Annexin-V-FITC/PI solution with 106 cells
was added into a EP tube and incubated for 15 min at
room temperature. Finally, 1 mL HEPES buffer was added
into the reaction tube, and the apoptosis index of the cells
was detected using FCM within 1 h.
Effect of p53 RNAi on ZR-75-30 and MDA-MB-231 apoptosis
To study the effect of the p53 RNAi on the high apop-
tosis indices of ZR-75-30 and MDA-MB-231, we con-
structed the pAd-p53-RNAi. Then, 1 × 105 BC cells were
inoculated into a 12-well plate. During transfection, the
plasmid mix was added gradually into each well that con-
tains tumor cells and media. The solution was mixed well
by gradual shaking. After 48 h transfection, cells were col-
lected via FCM method to detect apoptosis.
Statistical analysis methods
All data were expressed as median values ± standard error
(SE). The statistical significance of the differences in the
measured values among groups was evaluated using one-
way ANOVA. For individual comparisons, an independent
unpaired t-test was used. All analyses were performed
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ference if p < 0.01 or p < 0.05.Consent
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for the publication of this report and any accompanying
images.
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